title: PharmGKB summary: venlafaxine pathway.
authors.affiliation: Departments of aGenetics bBioengineering, Stanford University, Stanford, California, USA cInstitute of Pharmacology of Natural Products & Clinical Pharmacology, University of Ulm, Ulm dResearch Division, Federal Institute of Drugs & Medical Devices (BfArM), Bonn, Germany eDepartment of Pharmacology and Toxicology, Institute of Biomedicine, University of Oulu, Oulu, Finland.
authors.forename: Katrin
authors.initials: K
authors.lastname: Sangkuhl
authors.forename: Julia C
authors.initials: JC
authors.lastname: Stingl
authors.forename: Miia
authors.initials: M
authors.lastname: Turpeinen
authors.forename: Russ B
authors.initials: RB
authors.lastname: Altman
authors.forename: Teri E
authors.initials: TE
authors.lastname: Klein
mesh_terms: D000818:Animals; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D003511:Cyclohexanols / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics* / Q000378:metabolism; D003863:Depression / Q000188:drug therapy* / Q000235:genetics; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D053858:Metabolic Networks and Pathways / Q000235:genetics; D051379:Mice; D010597:Pharmacogenetics; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology; D013379:Substrate Specificity; D000069470:Venlafaxine Hydrochloride
chemical_list: D001189:Aryl Hydrocarbon Hydroxylases; D003511:Cyclohexanols; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride; C045793:CYP2C19 protein, human